Published in Circ Res on August 14, 2003
Casq2 deletion causes sarcoplasmic reticulum volume increase, premature Ca2+ release, and catecholaminergic polymorphic ventricular tachycardia. J Clin Invest (2006) 4.06
RyR2 mutations linked to ventricular tachycardia and sudden death reduce the threshold for store-overload-induced Ca2+ release (SOICR). Proc Natl Acad Sci U S A (2004) 3.25
Ryanodine receptors: structure, expression, molecular details, and function in calcium release. Cold Spring Harb Perspect Biol (2010) 2.46
Inherited dysfunction of sarcoplasmic reticulum Ca2+ handling and arrhythmogenesis. Circ Res (2011) 2.37
Kinetics of FKBP12.6 binding to ryanodine receptors in permeabilized cardiac myocytes and effects on Ca sparks. Circ Res (2010) 2.29
Dantrolene rescues arrhythmogenic RYR2 defect in a patient-specific stem cell model of catecholaminergic polymorphic ventricular tachycardia. EMBO Mol Med (2012) 1.93
Flecainide therapy reduces exercise-induced ventricular arrhythmias in patients with catecholaminergic polymorphic ventricular tachycardia. J Am Coll Cardiol (2011) 1.89
Stabilization of cardiac ryanodine receptor prevents intracellular calcium leak and arrhythmias. Proc Natl Acad Sci U S A (2006) 1.87
Cardiac ryanodine receptors control heart rate and rhythmicity in adult mice. Cardiovasc Res (2012) 1.77
Calcium cycling proteins and heart failure: mechanisms and therapeutics. J Clin Invest (2013) 1.74
Mutations in JPH2-encoded junctophilin-2 associated with hypertrophic cardiomyopathy in humans. J Mol Cell Cardiol (2007) 1.70
Increased Ca2+ sensitivity of the ryanodine receptor mutant RyR2R4496C underlies catecholaminergic polymorphic ventricular tachycardia. Circ Res (2008) 1.67
Cellular mechanisms underlying the development of catecholaminergic ventricular tachycardia. Circulation (2005) 1.50
Inherited calcium channelopathies in the pathophysiology of arrhythmias. Nat Rev Cardiol (2012) 1.44
Localization of an NH(2)-terminal disease-causing mutation hot spot to the "clamp" region in the three-dimensional structure of the cardiac ryanodine receptor. J Biol Chem (2007) 1.43
Loss of luminal Ca2+ activation in the cardiac ryanodine receptor is associated with ventricular fibrillation and sudden death. Proc Natl Acad Sci U S A (2007) 1.38
Endoplasmic reticulum Ca(2+) handling in excitable cells in health and disease. Pharmacol Rev (2011) 1.38
Ryanodine receptor channelopathies. Pflugers Arch (2010) 1.33
Localization of a disease-associated mutation site in the three-dimensional structure of the cardiac muscle ryanodine receptor. J Biol Chem (2005) 1.32
Junctophilin-2 expression silencing causes cardiocyte hypertrophy and abnormal intracellular calcium-handling. Circ Heart Fail (2011) 1.32
Ryanodine receptors: structure and function. J Biol Chem (2012) 1.30
K201 (JTV519) suppresses spontaneous Ca2+ release and [3H]ryanodine binding to RyR2 irrespective of FKBP12.6 association. Biochem J (2007) 1.27
Three-dimensional localization of serine 2808, a phosphorylation site in cardiac ryanodine receptor. J Biol Chem (2007) 1.24
Ryanodine receptor regulation by intramolecular interaction between cytoplasmic and transmembrane domains. Mol Biol Cell (2004) 1.20
Efficacy and potency of class I antiarrhythmic drugs for suppression of Ca2+ waves in permeabilized myocytes lacking calsequestrin. J Mol Cell Cardiol (2011) 1.19
Probing a putative dantrolene-binding site on the cardiac ryanodine receptor. Biochem J (2005) 1.15
Cardiac and skeletal muscle disorders caused by mutations in the intracellular Ca2+ release channels. J Clin Invest (2005) 1.13
The ryanodine receptor in cardiac physiology and disease. Adv Pharmacol (2010) 1.09
Dysfunctional ryanodine receptors in the heart: new insights into complex cardiovascular diseases. J Mol Cell Cardiol (2013) 1.08
Ryanodine receptors. Skelet Muscle (2011) 1.06
Three-dimensional visualization of FKBP12.6 binding to an open conformation of cardiac ryanodine receptor. Biophys J (2005) 1.03
Physiological consequences of the P2328S mutation in the ryanodine receptor (RyR2) gene in genetically modified murine hearts. Acta Physiol (Oxf) (2008) 0.98
A case of catecholaminergic polymorphic ventricular tachycardia. Yonsei Med J (2009) 0.98
Luminal Ca2+ controls activation of the cardiac ryanodine receptor by ATP. J Gen Physiol (2012) 0.94
Identification of novel missense mutations of cardiac ryanodine receptor gene in exercise-induced sudden death at autopsy. J Mol Diagn (2006) 0.93
Altered Ca2+ sparks in aging skeletal and cardiac muscle. Ageing Res Rev (2008) 0.90
Characterization of a novel mutation in the cardiac ryanodine receptor that results in catecholaminergic polymorphic ventricular tachycardia. Channels (Austin) (2010) 0.89
Spontaneous Ca2+ sparks and Ca2+ homeostasis in a minimal model of permeabilized ventricular myocytes. Am J Physiol Heart Circ Physiol (2010) 0.89
In situ confocal imaging in intact heart reveals stress-induced Ca(2+) release variability in a murine catecholaminergic polymorphic ventricular tachycardia model of type 2 ryanodine receptor(R4496C+/-) mutation. Circ Arrhythm Electrophysiol (2012) 0.88
A network-oriented perspective on cardiac calcium signaling. Am J Physiol Cell Physiol (2012) 0.87
Catecholaminergic-induced arrhythmias in failing cardiomyocytes associated with human HRCS96A variant overexpression. Am J Physiol Heart Circ Physiol (2011) 0.87
Prevention of ventricular arrhythmia and calcium dysregulation in a catecholaminergic polymorphic ventricular tachycardia mouse model carrying calsequestrin-2 mutation. J Cardiovasc Electrophysiol (2010) 0.86
Arrhythmogenesis in a catecholaminergic polymorphic ventricular tachycardia mutation that depresses ryanodine receptor function. Proc Natl Acad Sci U S A (2015) 0.85
The molecular basis of catecholaminergic polymorphic ventricular tachycardia: what are the different hypotheses regarding mechanisms? Heart Rhythm (2006) 0.83
TMEM43 mutation p.S358L alters intercalated disc protein expression and reduces conduction velocity in arrhythmogenic right ventricular cardiomyopathy. PLoS One (2014) 0.83
Sarcoplasmic reticulum Ca2+ release channel ryanodine receptor (RyR2) plays a crucial role in aconitine-induced arrhythmias. Biochem Pharmacol (2008) 0.82
Multiple modes of ryanodine receptor 2 inhibition by flecainide. Mol Pharmacol (2014) 0.80
Genetic bases of arrhythmogenic right ventricular Cardiomyopathy. Heart Int (2006) 0.80
Pathogenesis of Arrhythmogenic Cardiomyopathy. Can J Cardiol (2015) 0.79
Investigations of the contribution of a putative glycine hinge to ryanodine receptor channel gating. J Biol Chem (2013) 0.78
Genetic factors in arrhythmogenic right ventricular cardiomyopathy: need for a DNA bank! Neth Heart J (2006) 0.78
A new system for profiling drug-induced calcium signal perturbation in human embryonic stem cell-derived cardiomyocytes. J Biomol Screen (2014) 0.78
Suppression of Induced microRNA-15b Prevents Rapid Loss of Cardiac Function in a Dicer Depleted Model of Cardiac Dysfunction. PLoS One (2013) 0.78
Arrhythmia-associated cardiac Ca²(+) cycling proteins and gene mutations. Wien Med Wochenschr (2012) 0.76
Cell models of arrhythmogenic cardiomyopathy: advances and opportunities. Dis Model Mech (2017) 0.75
Defective interactions of protein partner with ion channels and transporters as alternative mechanisms of membrane channelopathies. Biochim Biophys Acta (2013) 0.75
Catecholaminergic polymorphic ventricular tachycardia in a patient with recurrent exertional syncope. Korean Circ J (2012) 0.75
Not all sudden death is the same. Circ Res (2003) 0.75
Calcium polymorphic ventricular tachycardia: a new name for CPVT? Cardiovasc Res (2010) 0.75
FK506-binding proteins 12 and 12.6 (FKBPs) as regulators of cardiac Ryanodine Receptors: insights from new functional and structural knowledge. Channels (Austin) (2017) 0.75
Murine Electrophysiological Models of Cardiac Arrhythmogenesis. Physiol Rev (2017) 0.75
PLC zeta: a sperm-specific trigger of Ca(2+) oscillations in eggs and embryo development. Development (2002) 3.13
Arrhythmogenesis in catecholaminergic polymorphic ventricular tachycardia: insights from a RyR2 R4496C knock-in mouse model. Circ Res (2006) 2.81
Characterization of a novel PKA phosphorylation site, serine-2030, reveals no PKA hyperphosphorylation of the cardiac ryanodine receptor in canine heart failure. Circ Res (2005) 1.86
Alternative splicing of ryanodine receptors modulates cardiomyocyte Ca2+ signaling and susceptibility to apoptosis. Circ Res (2007) 1.83
Functional heterogeneity of ryanodine receptor mutations associated with sudden cardiac death. Cardiovasc Res (2004) 1.72
Ryanodine receptor type I and nicotinic acid adenine dinucleotide phosphate receptors mediate Ca2+ release from insulin-containing vesicles in living pancreatic beta-cells (MIN6). J Biol Chem (2003) 1.59
Ryanodine receptors and ventricular arrhythmias: emerging trends in mutations, mechanisms and therapies. J Mol Cell Cardiol (2006) 1.55
Role of phospholipase C-zeta domains in Ca2+-dependent phosphatidylinositol 4,5-bisphosphate hydrolysis and cytoplasmic Ca2+ oscillations. J Biol Chem (2005) 1.26
Arrhythmogenic mutation-linked defects in ryanodine receptor autoregulation reveal a novel mechanism of Ca2+ release channel dysfunction. Circ Res (2005) 1.26
Na+-dependent SR Ca2+ overload induces arrhythmogenic events in mouse cardiomyocytes with a human CPVT mutation. Cardiovasc Res (2010) 1.22
Ca2+ syntillas, miniature Ca2+ release events in terminals of hypothalamic neurons, are increased in frequency by depolarization in the absence of Ca2+ influx. J Neurosci (2004) 1.22
Ryanodine receptor regulation by intramolecular interaction between cytoplasmic and transmembrane domains. Mol Biol Cell (2004) 1.20
Ryanodine stores and calcium regulation in the inner segments of salamander rods and cones. J Physiol (2003) 1.15
Physical coupling between ryanodine receptor-calcium release channels. J Mol Biol (2005) 1.14
Mineralocorticoid modulation of cardiac ryanodine receptor activity is associated with downregulation of FK506-binding proteins. Circulation (2009) 1.14
PLCzeta, a sperm-specific PLC and its potential role in fertilization. Biochem Soc Symp (2007) 1.14
Redox sensitivity of the ryanodine receptor interaction with FK506-binding protein. J Biol Chem (2007) 1.13
Binding of phosphoinositide-specific phospholipase C-zeta (PLC-zeta) to phospholipid membranes: potential role of an unstructured cluster of basic residues. J Biol Chem (2007) 1.11
Ryanodine receptor-mediated arrhythmias and sudden cardiac death. Pharmacol Ther (2009) 1.08
Interaction of FKBP12.6 with the cardiac ryanodine receptor C-terminal domain. J Biol Chem (2004) 1.07
PLCζ and the initiation of Ca(2+) oscillations in fertilizing mammalian eggs. Cell Calcium (2012) 1.04
Dihydropyridine receptors and type 1 ryanodine receptors constitute the molecular machinery for voltage-induced Ca2+ release in nerve terminals. J Neurosci (2006) 1.02
Role of FKBP12.6 in hypoxia- and norepinephrine-induced Ca2+ release and contraction in pulmonary artery myocytes. Cell Calcium (2004) 1.02
Two-dimensional crystallization of the ryanodine receptor Ca2+ release channel on lipid membranes. J Struct Biol (2005) 1.01
Male infertility-linked point mutation disrupts the Ca2+ oscillation-inducing and PIP(2) hydrolysis activity of sperm PLCζ. Biochem J (2011) 1.01
Use of luciferase chimaera to monitor PLCzeta expression in mouse eggs. Methods Mol Biol (2009) 1.00
Starting a new life: sperm PLC-zeta mobilizes the Ca2+ signal that induces egg activation and embryo development: an essential phospholipase C with implications for male infertility. Bioessays (2011) 1.00
Oligomerization of the cardiac ryanodine receptor C-terminal tail. Biochem J (2003) 1.00
Differential Ca2+ sensitivity of RyR2 mutations reveals distinct mechanisms of channel dysfunction in sudden cardiac death. Biochem Biophys Res Commun (2005) 0.99
A mechanism of ryanodine receptor modulation by FKBP12/12.6, protein kinase A, and K201. Cardiovasc Res (2010) 0.98
Phospholipase Cζ binding to PtdIns(4,5)P2 requires the XY-linker region. J Cell Sci (2011) 0.98
Redistribution of mitochondria leads to bursts of ATP production during spontaneous mouse oocyte maturation. J Cell Physiol (2010) 0.97
Syntillas release Ca2+ at a site different from the microdomain where exocytosis occurs in mouse chromaffin cells. Biophys J (2005) 0.96
Phospholipase Cζ rescues failed oocyte activation in a prototype of male factor infertility. Fertil Steril (2012) 0.95
Disparities in the association of the ryanodine receptor and the FK506-binding proteins in mammalian heart. J Cell Sci (2012) 0.95
PLCζ causes Ca(2+) oscillations in mouse eggs by targeting intracellular and not plasma membrane PI(4,5)P(2). Mol Biol Cell (2011) 0.94
Presenilins regulate calcium homeostasis and presynaptic function via ryanodine receptors in hippocampal neurons. Proc Natl Acad Sci U S A (2013) 0.94
Ryanodine receptor arrays: not just a pretty pattern? Trends Cell Biol (2008) 0.93
Ryanodine receptor interaction with the SNARE-associated protein snapin. J Cell Sci (2006) 0.93
Isoform-dependent formation of heteromeric Ca2+ release channels (ryanodine receptors). J Biol Chem (2002) 0.91
Dysregulated ryanodine receptors mediate cellular toxicity: restoration of normal phenotype by FKBP12.6. J Biol Chem (2003) 0.91
Selective cognitive impairment in the YAC128 Huntington's disease mouse. Brain Res Bull (2011) 0.89
Spatial organization of RYRs and BK channels underlying the activation of STOCs by Ca(2+) sparks in airway myocytes. J Gen Physiol (2011) 0.88
Novel regulation of PLCζ activity via its XY-linker. Biochem J (2011) 0.88
Cell cycle-dependent Ca2+ oscillations in mouse embryos are regulated by nuclear targeting of PLCzeta. J Cell Sci (2004) 0.88
Sperm PLCζ: from structure to Ca2+ oscillations, egg activation and therapeutic potential. FEBS Lett (2013) 0.87
Modification of smooth muscle Ca2+-sparks by tetracaine: evidence for sequential RyR activation. Cell Calcium (2007) 0.86
Central domain of the human cardiac muscle ryanodine receptor does not mediate interaction with FKBP12.6. Cell Biochem Biophys (2005) 0.85
Regulation of diacylglycerol production and protein kinase C stimulation during sperm- and PLCzeta-mediated mouse egg activation. Biol Cell (2008) 0.85
Longitudinal analysis of gene expression and behaviour in the HdhQ150 mouse model of Huntington's disease. Brain Res Bull (2011) 0.83
N-terminus oligomerization regulates the function of cardiac ryanodine receptors. J Cell Sci (2013) 0.83
Developing new anti-arrhythmics: clues from the molecular basis of cardiac ryanodine receptor (RyR2) Ca2+-release channel dysfunction. Curr Pharm Des (2007) 0.83
The dynamics of PKC-induced phosphorylation triggered by Ca2+ oscillations in mouse eggs. J Cell Physiol (2013) 0.83
FKBP12.6 binding of ryanodine receptors carrying mutations associated with arrhythmogenic cardiac disease. Biochem J (2009) 0.83
Toward a molecular understanding of the structure-function of ryanodine receptor Ca2+ release channels: perspectives from recombinant expression systems. Cell Biochem Biophys (2005) 0.82
Is PAWP the "real" sperm factor? Asian J Androl (2015) 0.82
Chimeras of sperm PLCζ reveal disparate protein domain functions in the generation of intracellular Ca2+ oscillations in mammalian eggs at fertilization. Mol Hum Reprod (2013) 0.82
Hax-1 identified as a two-pore channel (TPC)-binding protein. FEBS Lett (2013) 0.82
In situ modulation of the human cardiac ryanodine receptor (hRyR2) by FKBP12.6. Biochem J (2003) 0.81
Phospholipase C-ζ-induced Ca2+ oscillations cause coincident cytoplasmic movements in human oocytes that failed to fertilize after intracytoplasmic sperm injection. Fertil Steril (2012) 0.81
Divergent effect of mammalian PLCζ in generating Ca²⁺ oscillations in somatic cells compared with eggs. Biochem J (2011) 0.81
ATP interacts with the CPVT mutation-associated central domain of the cardiac ryanodine receptor. Biochim Biophys Acta (2013) 0.78
Molecular nature of sulfhydryl modification by hydrogen peroxide on type 1 ryanodine receptor. Acta Pharmacol Sin (2006) 0.78
Genetic and Biochemical Approaches for In Vivo and In Vitro Assessment of Protein Oligomerization: The Ryanodine Receptor Case Study. J Vis Exp (2016) 0.77
Bioinformatic mapping and production of recombinant N-terminal domains of human cardiac ryanodine receptor 2. Protein Expr Purif (2010) 0.76
Ryanodine receptor binding to FKBP12 is modulated by channel activation state. J Cell Sci (2005) 0.76
Ryanodine receptor dysfunction in arrhythmia and sudden cardiac death. Future Cardiol (2005) 0.75
CMV promoter is inadequate for expression of mutant human RyR2 in transgenic rabbits. J Pharmacol Toxicol Methods (2010) 0.75
Ryanodine receptor oligomeric interaction: identification of a putative binding region. J Biol Chem (2004) 0.75